Article

Prevalence of Significant and Advanced Hepatic Fibrosis in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)

2021-08-30

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> There are several reports on the prevalence of metabolic dysfunction associated fatty liver disease (MAFLD) in the general population. But the fibrosis burden of MAFLD in general population is largely unknown. We aimed to evaluate the prevalence of significant and advanced fibrosis associated with MAFLD in a health check-up cohort.<bold>Materials and methods:</b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2c9dbfbf-d921-518a-9972-b1b15f40920c
DOI: 10.21203/rs.3.rs-799868/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prevalence of Significant and Advanced Hepatic Fibrosis in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)DOI 10.21203/rs.3.rs-799868/v1Read

Unveiling the Burden of MASLD and Liver Fibrosis in India: Novel Insights from the Phenome India Study into fibrosis without MASLDSemantic proximity Read

Prevalence Of Fatty Liver Disease And Associated Factors Among Outpatients At Muhas Academic Medical Centre,tanzaniaSemantic proximity Read

Impact Of Thyroid Dysfunction And Diabetes On Fibrosis And Steatosis Stages In Nonalcoholic Fatty Liver DiseaseSemantic proximity Read

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read

Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population.Semantic proximity Read

Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult PopulationSemantic proximity Read

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.Semantic proximity Read

Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated alcohol‑related liver disease represent distinct clinical phenotypes and fibrosis risks: insights from a population-based Polish cohort.Semantic proximity Read

[Precise clinical classification of metabolic associated fatty liver disease].Semantic proximity Read

Recent advances in understanding and managing non-alcoholic fatty liver diseaseSemantic proximity Read

Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.Semantic proximity Read

FIB-4 First in Diagnostic Algorithm of MAFLD at the Era of “Global Metabodemic “Semantic proximity Read